Services
AI Supported Consent Acceleration
Activate the right clinicians and secure consent.
Targeted, GDPR-aligned consent programmes combine precise AI-supported clinician identification for pre-approved communication. This enables relevant engagement, higher opt-in rates, and validated consents delivered directly into your CRM through a success-based model.
Obtaining compliant clinician consent has become both more complex and more important. This is because regulatory requirements are stricter and effective engagement requires relevance, prevision and trust. Consent refers to the explicit permission from clinicians to be contacted and engaged by organisations in a compliant and transparent manner.
Global Data Support provides GDPR-aligned consent programmes built on precise AI driven clinician identification for approved communication. This approach drives higher opt-in rates, ensures fully validated consents, and enables structured delivery directly into the organisation’s CRM, with outcomes tied to performance
We identify the clinicians for whom requesting consent is relevant based on their clinical activity, scientific involvement, and alignment with the organisation’s objectives. We call this social listening.
Using AI-driven analysis, we optimise how each relevant clinician is approached by determining:
- The most relevant message
- The most appropriate value proposition
- The optimal communication approach
- Alignment with the organisation’s product and strategic priorities
All communication is tailored to the clinician, ensuring that engagement is meaningful and specific. Instead of consent being driven by volume of outreach, it is driven by relevance. Engagement is tailored to each clinician’s role in the patient pathway.
Example
For example, for a clinician who encounters Fabry patients primarily through early symptoms and misdiagnosis pathways, communication may focus on:
- Increasing awareness of Fabry and its clinical presentation
- Educational resources supporting earlier recognition
For specialists actively managing Fabry patients, the message may instead emphasise:
- Clinical experience and management of confirmed cases
- Updates on emerging therapies
- Opportunities for collaboration, research, or advanced education
All content is developed within regulatory frameworks and pre-approved before being sent to clinicians. We ensure alignment with GDPR requirements, national consent and opt-in regulations, and double opt-in processes where required (e.g. Germany).
All consent processes will be made secure, fully traceable, properly documented and auditable, and validated prior to delivery. All consents are delivered into the organisation’s CRM in structured, ready-to-use formats.
The result
Through precise targeting and relevant engagement, our AI supported consent programmes consistently achieve strong results. Depending on the market and indication, opt-in rates exceeding 70% are not uncommon.
This targeted approach can also significantly reduce the costs per opt-in. By focusing only on clinicians for whom the message is relevant and tailoring communication to their role and interest, higher conversion rates can be achieved. As a result, fewer contacts are required to achieve results, lowering the overall costs.
We also operate on a performance-based approach, meaning that organisations only pay for successfully captured and validated consents. This ensures full alignment between effort, quality and outcomes.